|
1
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lunt SY and Vander Heiden MG: Aerobic
glycolysis: Meeting the metabolic requirements of cell
proliferation. Annu Rev Cell Dev Biol. 27:441–464. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwartz L, Supuran CT and Alfarouk KO:
The Warburg effect and the Hallmarks of cancer. Anticancer Agents
Med Chem. 17:164–170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ganapathy-Kanniappan S and Geschwind JF:
Tumor glycolysis as a target for cancer therapy: Progress and
prospects. Mol Cancer. 12:1522013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Peng Y, Li J, Chen Z, Chen F, Tu J,
Lin S and Wang H: N6-methyladenosine regulates
glycolysis of cancer cells through PDK4. Nat Commun. 11:25782020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kroemer G and Pouyssegur J: Tumor cell
metabolism: Cancer's Achilles' heel. Cancer Cell. 13:472–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: Metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bushati N and Cohen SM: MicroRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sadri Nahand J, Moghoofei M, Salmaninejad
A, Bahmanpour Z, Karimzadeh M, Nasiri M, Mirzaei HR, Pourhanifeh
MH, Bokharaei-Salim F, Mirzaei H and Hamblin MR: Pathogenic role of
exosomes and microRNAs in HPV-mediated inflammation and cervical
cancer: A review. Int J Cancer. 146:305–320. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pardini B, De Maria D, Francavilla A, Di
Gaetano C, Ronco G and Naccarati A: MicroRNAs as markers of
progression in cervical cancer: A systematic review. BMC Cancer.
18:6962018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao C, Zhou C, Zhuang J, Liu L, Liu C, Li
H, Liu G, Wei J and Sun C: MicroRNA expression in cervical cancer:
Novel diagnostic and prognostic biomarkers. J Cell Biochem.
119:7080–7090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun D, Han L, Cao R, Wang H, Jiang J, Deng
Y and Yu X: Prediction of a miRNA-mRNA functional synergistic
network for cervical squamous cell carcinoma. FEBS Open Bio.
9:2080–2092. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Di Malta C, Siciliano D, Calcagni A,
Monfregola J, Punzi S, Pastore N, Eastes AN, Davis O, De Cegli R,
Zampelli A, et al: Transcriptional activation of RagD GTPase
controls mTORC1 and promotes cancer growth. Science. 356:1188–1192.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Chang L, Li Z, Gao Q, Cai D, Tian
Y, Zeng L and Li M: MiR-99a and −99b inhibit cervical cancer cell
proliferation and invasion by targeting mTOR signaling pathway. Med
Oncol. 31:9342014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ribas V, García-Ruiz C and Fernández-Checa
JC: Mitochondria, cholesterol and cancer cell metabolism. Clin
Transl Med. 5:222016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding L and Liang X: Ras related GTP
binding D promotes aerobic glycolysis of hepatocellular carcinoma.
Ann Hepatol. 23:1003072021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Li B, Yang X and Zhang C:
MiR-99a-5p inhibits bladder cancer cell proliferation by directly
targeting mammalian target of rapamycin and predicts patient
survival. J Cell Biochem. 120:19330–19337. 2019. View Article : Google Scholar : PubMed/NCBI
|
